R. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest. 1999 Apr;115(4):1076-84. \[[PubMed: 10208211](https://pubmed.ncbi.nlm.nih.gov/10208211)\] 7. Baselski VS, el-Torky M, Coalson JJ, Griffin JP. The standardization of criteria for processing and interpreting laboratory specimens in patients with suspected ventilator-associated pneumonia. Chest. 1992 Nov;102(5 Suppl 1):571S-579S. \[[PubMed: 1424932](https://pubmed.ncbi.nlm.nih.gov/1424932)\] 8. Burrack-Lange SC, Personne Y, Huber M, Winkler E, Weile J, Knabbe C, Görig J, Rohde H. Multicenter assessment of the rapid Unyvero Blood Culture molecular assay. J Med Microbiol. 2018 Sep;67(9):1294-1301. \[[PMC free article: PMC6230722](/pmc/articles/PMC6230722/)\] \[[PubMed: 30051799](https://pubmed.ncbi.nlm.nih.gov/30051799)\] 9. Luyt CE, Hékimian G, Koulenti D, Chastre J. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia. Curr Opin Crit Care. 2018 Oct;24(5):332-338. \[[PubMed: 30036192](https://pubmed.ncbi.nlm.nih.gov/30036192)\] 10. Karakuzu Z, Iscimen R, Akalin H, Kelebek Girgin N, Kahveci F, Sinirtas M. Prognostic Risk Factors in Ventilator-Associated Pneumonia. Med Sci Monit. 2018 Mar 05;24:1321-1328. \[[PMC free article: PMC5848715](/pmc/articles/PMC5848715/)\] \[[PubMed: 29503436](https://pubmed.ncbi.nlm.nih.gov/29503436)\] **Disclosure:** Eman Shebl declares no relevant financial relationships with ineligible companies. **Disclosure:** Peter Gulick declares no relevant financial relationships with ineligible companies.